Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank13
3Y CAGR-9.5%
5Y CAGR-21.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-9.5%/yr
vs +1.9%/yr prior
5Y CAGR
-21.8%/yr
Recent acceleration
Acceleration
-11.4pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $84.22M | -34.2% |
| 2024 | $127.98M | -33.1% |
| 2023 | $191.44M | +68.6% |
| 2022 | $113.56M | -21.6% |
| 2021 | $144.90M | -49.6% |
| 2020 | $287.31M | +29.1% |
| 2019 | $222.47M | +111.1% |
| 2018 | $105.40M | +5765.3% |
| 2017 | $1.80M | - |